Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 263,136 | 362,578 | 315,573 | 219,499 | 186,120 |
| Marketable Securities | 175,924 | 50,311 | 50,855 | 101,220 | 101,235 |
| Receivables | 50,112 | 44,660 | 47,826 | 50,814 | 53,781 |
| Inventories | 21,416 | 20,546 | 20,327 | 25,020 | 24,254 |
| TOTAL | $522,175 | $488,376 | $449,224 | $414,681 | $383,152 |
| Non-Current Assets | |||||
| PPE Net | 22,652 | 22,192 | 18,900 | 18,552 | 22,529 |
| Intangibles | 853,017 | 856,302 | 859,631 | 869,061 | 853,366 |
| Other Non-Current Assets | 38,556 | 39,149 | 40,032 | 41,810 | 56,364 |
| TOTAL | $914,225 | $917,643 | $918,563 | $929,423 | $932,259 |
| Total Assets | $1,436,400 | $1,406,019 | $1,367,787 | $1,344,104 | $1,315,411 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,908 | 4,593 | 5,509 | 11,447 | 15,709 |
| Accrued Expenses | 43,129 | 48,801 | 48,373 | 43,707 | 35,928 |
| Other current liabilities | 982 | 1,332 | 13,571 | 13,415 | 14,367 |
| TOTAL | $56,115 | $59,937 | $72,152 | $76,433 | $75,125 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 749 | 1,160 | 417 | 1,450 | 1,712 |
| Other Non-Current Liabilities | 35,243 | 35,860 | 36,754 | 45,313 | 44,108 |
| TOTAL | $35,879 | $36,506 | $37,968 | $46,614 | $45,350 |
| Total Liabilities | $91,994 | $96,443 | $110,120 | $123,047 | $120,475 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 79,793 | 79,458 | 79,049 | 78,672 | 78,315 |
| Common Shares | 80 | 79 | 79 | 79 | 78 |
| Retained earnings | -348,923 | -377,630 | -418,779 | -437,916 | -436,936 |
| Other shareholders' equity | -8,221 | -8,212 | -8,220 | -11,959 | -28,641 |
| TOTAL | $1,344,406 | $1,309,576 | $1,257,667 | $1,221,057 | $1,194,936 |
| Total Liabilities And Equity | $1,436,400 | $1,406,019 | $1,367,787 | $1,344,104 | $1,315,411 |